by Richard Daverman, PhD
January 8, 2013 -- China has ordered the fourth major round of price reductions for drugs, cutting prices by an average of 15%. More expensive drugs will see 20% reductions. The latest set of decreases, which are scheduled to start in February, will include many drugs from international big pharma. The cuts affect about 400 drugs that belong to 20 broad classes. We include a list of big pharma’s products that are included in the latest round. More details....
